Text Size

Aging and Cancer Effects (ACE) Study

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00204880
First received: September 13, 2005
Last updated: September 28, 2010
Last verified: September 2010
History of Changes
  Purpose

Hypotheses:

  1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains.
  2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer.
  3. Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.

Condition
Breast Cancer
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Enrollment: 34
Study Start Date: February 2005
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Men and women over the age of 55 newly diagnosed with lung, breast, colon or rectal cancer, and with an anticipated life expectancy of at least 2 years for breast cancer patients,1 year for patients with lung cancer, and 2 years for patients with colon or rectal cancer. There is no upper age limit for participation in this study.

Criteria

Inclusion Criteria:

  • Willing to do memory testing
  • Willing to participate in activities of daily living assessment
  • Can use a cane or walker
  • Willing to complete a balance performance assessment, if able.

Exclusion Criteria:

  • Currently receiving treatment for cancer.
  • Has a previous history of brain cancer
  • Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00204880

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Sanjay Asthana, MD University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Sanjay Asthana, University of Wisconsin
ClinicalTrials.gov Identifier: NCT00204880     History of Changes
Other Study ID Numbers: 2004-0341
Study First Received: September 13, 2005
Last Updated: September 28, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Lung Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
 Skin Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 23, 2013